Eyenovia, Inc. (NASDAQ:EYEN) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET

Company Participants

Eric Ribner - Investor Relations

Sean Ianchulev - Chairman

Michael Rowe - Chief Executive Officer

John Gandolfo - Chief Financial Officer

Conference Call Participants

Matt Kaplan - Ladenburg Thalmann

Leonard Yaffe - Stoc Doc Partners

Operator

Ladies and gentlemen, greetings and welcome to the Eyenovia Second Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.

I will now turn the conference over to Eric Ribner of LifeSci Advisors. Please go ahead, sir.

Eric Ribner

Thanks very much and good afternoon and welcome to Eyenovia’s second quarter 2022 earnings conference call and audio webcast. With me today are Eyenovia’s Chairman, Dr. Sean Ianchulev; Chief Executive Officer, Michael Rowe; and Chief Financial Officer, John Gandolfo.

This afternoon, Eyenovia issued a press release announcing financial results for the 3 months ended June 30, 2022. We encourage everyone to read today’s press release as well as Eyenovia’s report on Form 10-K for the year ended December 31, 2021 which was filed with the SEC March 30, 2022 and our most recently filed 10-Q. The company’s press release and annual report are also available on Eyenovia’s website at www.eyenovia.com. In addition, this conference call is being webcast through the company’s website and will be archived there for future reference.

Please note, on today’s call, we will be discussing investigational products candidates which have yet to receive FDA approval. Please also note that certain information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that during this call, Eyenovia’s management will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company’s business. These forward-looking statements are subject to a number of risks which are described in more detail in our annual report on Form 10-K and most recently filed 10-Q. This conference call contains time-sensitive information accurate only as of the date of this live broadcast, August 10, 2022. Eyenovia undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as may be required by applicable securities law.

With that said, I’d like to turn the call over to Dr. Sean Ianchulev, Chairman of Eyenovia’s Board of Directors. Sean?